Congress Mulls Adding “Economic Growth” To FDA Mission Statement
This article was originally published in The Tan Sheet
As PDUFA hearings start, Commissioner Hamburg says considering the jobs affected by the approval or denial of an application would be difficult and inappropriate. Rep. Rogers and Sen. Coats author bills to require changing FDA’s mission statement in program renewal.
You may also be interested in...
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees
The tentative agreement of $595 million in user fees over five years is more than companies had wanted to spend. But industry negotiators insist it is a good deal, tied to performance goals and process improvements they say will ensure greater speed and predictability in reaching the U.S. market.
Accelerated Approval Expansion Proposals Pending, But One Needs An Overhaul
ULTRA bill will need changes to gain the support of influential patient group. Meanwhile, BIO is circulating a proposal to make changes to existing regulations.